James Kupiec's Insider Trades & SAST Disclosures
James Kupiec's most recent trade in Cassava Sciences Inc was a trade of 4,000 Common Stock done at an average price of $3.9 . Disclosure was reported to the exchange on Nov. 29, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern James Kupiec.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cassava Sciences Inc | James Kupiec W. | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 3.87 per share. | 29 Nov 2024 | 4,000 | 0 (0%) | 0% | 3.9 | 15,480 | Common Stock |
| Cassava Sciences Inc | James W. Kupiec | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Cassava Sciences Inc | James W. Kupiec | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Cassava Sciences Inc | James W. Kupiec | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.00 per share. | 18 Apr 2024 | 1,500 | 4,000 (0%) | 0% | 22 | 33,000 | Common Stock |
| Cassava Sciences Inc | James W. Kupiec | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 1,000 | 1,000 | - | - | Common Stock Warrant | |
| Cassava Sciences Inc | James W. Kupiec | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Apr 2024 | 1,000 | 0 | - | - | Common Stock Warrant | |
| Cassava Sciences Inc | James Kupiec | Chief Clinical Dev. Officer | Purchase of securities on an exchange or from another person at price $ 24.44 per share. | 23 Aug 2022 | 2,500 | 2,500 (0%) | 0% | 24.4 | 61,100 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges